PortViewPortView
Sanara MedTech logo

Sanara MedTech (SMTI) Stock Analysis

NASDAQHealthcareMedical - Instruments & Supplies

$34.85+0.17%
1-year price historyRange $16.34 – $35.75
52-week range$34.85
$16.05$35.95

What Sanara MedTech does

Sanara MedTech Inc. is a Fort Worth, Texas-based company established in 2001, dedicated to the development, marketing, and distribution of advanced wound and skin care products. These solutions are provided to a diverse clientele within the United States healthcare sector, including physicians, hospitals, clinics, and post-acute care facilities. The company's extensive product portfolio includes CellerateRX, a line of Surgical Activated Collagen in both powder and gel forms, designed to enhance patient healing across various surgical specialties. Sanara MedTech also offers a suite of Biako's antimicrobial products: a patented Skin and Wound Cleanser engineered to dismantle mature biofilm microbes by disrupting their extracellular polymeric substances, an Antimicrobial Wound Gel effective against both planktonic and biofilm-forming microbes, and an Antimicrobial Skin and Wound Irrigation Solution. Another key offering is HYCOL, a hydrolyzed Type I bovine collagen available as powder and gel, specifically formulated for the management of both full and partial thickness wounds, encompassing conditions such as pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. Additionally, Sanara MedTech is involved in the development of sophisticated biologic devices like FORTIFY TRG, a freeze-dried, multi-layer sheet derived from small intestinal submucosa extracellular matrix, and FORTIFY FLOWABLE extracellular matrix, an innovative wound care solution. The company also provides VIM Amnion Matrix, a single-layer amnion tissue sheet. Initially incorporated as WNDM Medical Inc., the company underwent a name change to Sanara MedTech Inc. in May 2019.

Key metrics

Market cap
$320.38M
P/E (TTM)
-580.83
EPS (TTM)
$-0.06
Beta
1.16
Dividend yield
0.00%
Revenue / share
$12.68
50-day avg
$29.34
200-day avg
$23.02
52-week high
$35.95
52-week low
$16.05
CEO
Seth D. Yon

ETFs linked to SMTI

Broad-market and Healthcare sector ETFs an investor holding Sanara MedTech is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SMTI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SMTI in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Sanara MedTech?
Sanara MedTech trades under the ticker SMTI on NASDAQ.
Which exchange is SMTI listed on?
SMTI is listed on NASDAQ.
What sector does Sanara MedTech operate in?
Sanara MedTech is classified in the Healthcare sector (Medical - Instruments & Supplies industry).
How can PortView help analyze SMTI in a portfolio?
PortView shows SMTI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.